General
United States resumes Johnson & Johnson vaccine rollout following 10-day pause over blood clot concerns
The United States can resume use of Johnson & Johnson’s COVID-19 vaccine immediately, top health regulators said on Friday, ending a 10-day pause to investigate the vaccine’s link to extremely rare but potentially deadly blood clots.
Key points:
- The CDC panel voted 10-4 that the Johnson & Johnson COVID-19 vaccine be recommended for use in people 18 years of age and older
- Johnson & Johnson’s chief scientific officer Paul Stoffels said the committee’s recommendation was “an essential step toward continuing urgently needed vaccinations”
- The FDA will update the emergency use authorisation for the vaccine to include information about the risk and how to recognise and treat the condition
The US Centres for Disease Control and Prevention (CDC)…
Continue Reading
-
General23 hours agoAmbulance response times sluggish despite Tasmanian ramping ‘ban’ promise
-
Noosa News21 hours agoBrisbane’s new bus timetable sees journey times decrease by two minutes in first three months
-
Business19 hours agoWhat it means for shareholders
-
Business22 hours agoUp 48% in a month, can Domino’s Pizza shares keep the momentum going?